Alnylam Pharmaceuticals | ALNY - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Amgen USD 51.89B 1.88B 2026-03
Arrowhead Research USD 1.23B 687.3M 2026-03
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Incyte USD 29.41M 785K 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Moderna USD 603M 7M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
PTC Therapeutics USD 286.94M 1.74B 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 150.06M 2025-12
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Takeda JPY 4.37T 99.51B 2026-03
Tectonic Therapeutic USD 43K 57K 2025-12
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Xencor USD 82.12M 5.64M 2026-03